All stock lists
Unlock the score
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
Healthcare · Biotechnology
0.77+0.01 (+1.02%)
Insider Score
/ 100
CMPX Insider Score
Compass Therapeutics, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
CMPX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | -100.00 % | — |
| Cost of Revenue | 0.00 | 368.00 K | 370.00 K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -368.00 K | -370.00 K | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 7.40 M | 6.56 M | 4.32 M | 2.99 M | 4.65 M | 4.91 M |
| R&D Expense | 19.58 M | 13.38 M | 13.67 M | 12.83 M | 16.41 M | 13.05 M |
| Operating Expenses | 26.98 M | 19.93 M | 17.62 M | 15.82 M | 21.07 M | 17.97 M |
| Operating Income | -26.98 M | -20.30 M | -17.99 M | -15.82 M | -21.07 M | -17.97 M |
| Pretax Income | -25.15 M | -18.32 M | -15.72 M | -14.26 M | -19.88 M | -16.63 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -25.15 M | -18.32 M | -15.72 M | -14.26 M | -19.88 M | -16.63 M |
| EPS (Basic) | -0.13 | -0.10 | -0.09 | -0.10 | -0.14 | -0.12 |
| EPS (Diluted) | -0.13 | -0.10 | -0.09 | -0.10 | -0.14 | -0.12 |
| Shares Outstanding | 186.80 M | 186.40 M | 184.84 M | 138.28 M | 138.28 M | 138.24 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.